Drappa Jorn
Chief Medical Officer
Drappa Jorn has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 5, 2026.
On the most recent filing, Drappa Jorn is listed as Chief Medical Officer at ALUMIS INC. Inside the rolling window, Drappa Jorn reported no open-market purchases and 1 open-market sale totaling $65K in ALMS.
Companies traded
Other insiders at ALMS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$65K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Drappa Jorn made?
Drappa Jorn has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Drappa Jorn trade?
Drappa Jorn has filed SEC Form 4 disclosures for 1 company, including ALMS.
When was Drappa Jorn's most recent SEC Form 4 filing?
Drappa Jorn's most recent SEC Form 4 filing on Tracefour is dated Aug 5, 2026.
What is Drappa Jorn's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Drappa Jorn is listed as Chief Medical Officer.
What is Drappa Jorn's total buy and sell value in the current window?
Inside the rolling retention window, Drappa Jorn bought $0 and sold $65K based on SEC Form 4 filings.
What was Drappa Jorn's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,447 ALMS shares on 2026-08-03, worth $65K, per SEC Form 4 filings.